Related Experiment Video
Updated: Jan 14, 2026
Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
Published on: June 2, 2015
Limited Effect of Remote Ischemic Preconditioning on Survival in Rodent Models of Sepsis
Eunji Ko1, Yun Hee Kim2, Soovin Lee3
1Department of Anesthesiology and Pain Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seongbuk-gu, Seoul, Republic of Korea.
Introduction:
Sepsis is a severe pathological crisis marked by infection and systemic inflammation with high mortality rates. Sepsis induces microcirculatory dysfunction and oxidative stress, which share pathophysiological features with ischemia-reperfusion injury. Remote ischemic preconditioning (RIPC), a method involving brief repeated cycles of limb ischemia and reperfusion, has been investigated as a potential strategy to improve outcomes in ischemia-reperfusion injury.
Methods:
This study aimed to examine the effect of RIPC on survival and serum chemical tests in two rat sepsis models. A total of 130 male Sprague-Dawley rats were used. The endotoxemia model was induced by intraperitoneal lipopolysaccharide (LPS) injection, and the peritonitis model was induced by cecal ligation and puncture (CLP). Serum chemical levels including total bilirubin, platelet count, blood urea nitrogen, creatinine, and lactate were measured according to the sepsis criteria.
Results:
In the LPS model, survival rates were 100% in control and RIPC-only groups, but decreased to 50% in the LPS group and 10% in the RIPC/LPS group (P = 0.012 and P < 0.001 versus control). In the CLP model, survival rates were 60% in both CLP and RIPC/CLP groups (P = 1.000). RIPC did not improve overall survival. While serum creatinine levels improved slightly in the RIPC/CLP group, other biochemical markers were unaffected by RIPC.
Conclusions:
Despite previous evidence in mice and sheep, RIPC did not improve survival or serum markers in rat sepsis models. The lack of benefit may reflect interspecies differences and highlights the need for further investigation before applying RIPC clinically in human sepsis.
Insights
Remote ischemic preconditioning (RIPC) did not improve survival in rat sepsis models, despite showing promise in other species. Further research is needed to determine its clinical efficacy in human sepsis patients.
Area of Science:
- Critical Care Medicine
- Surgical Research
- Translational Medicine
Background:
- Sepsis is a life-threatening condition characterized by infection and systemic inflammation, leading to high mortality.
- Sepsis-induced microcirculatory dysfunction and oxidative stress share similarities with ischemia-reperfusion injury.
- Remote ischemic preconditioning (RIPC) is a potential intervention for ischemia-reperfusion injury.
Purpose of the Study:
- To evaluate the impact of RIPC on survival rates and serum biochemical markers in rat models of sepsis.
- To investigate RIPC's efficacy in endotoxemia (lipopolysaccharide-induced) and peritonitis (cecal ligation and puncture) sepsis models.
Main Methods:
- 130 male Sprague-Dawley rats were used in two sepsis models: endotoxemia (LPS injection) and peritonitis (CLP).
- RIPC was applied before sepsis induction in experimental groups.
- Serum levels of total bilirubin, platelets, BUN, creatinine, and lactate were measured.
Main Results:
- In the LPS model, RIPC/LPS group showed significantly reduced survival (10%) compared to control.
- In the CLP model, RIPC did not alter survival rates (60% in both CLP and RIPC/CLP groups).
- RIPC showed no significant improvement in overall survival or most serum biochemical markers, except for a slight improvement in creatinine in the RIPC/CLP group.
Conclusions:
- RIPC failed to improve survival or key serum markers in established rat sepsis models.
- Observed lack of efficacy may be due to interspecies differences compared to mice and sheep studies.
- Further investigation is warranted to explore RIPC's potential clinical application in human sepsis.
